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Abstract
Objective: The objective was to verify the skill of nurses about the 
use of collagenase in the treatment of chronic wounds.
Method: A descriptive study of a qualitative approach performed 
with medical clinic nurses from two hospitals. The data were collected 
processed using the content analysis technique.
Results: Worked categories: 1. Knowledge about the mechanisms of 
action of collagenase in the treatment of chronic wounds. 2. Reasons 
for use and destruction of collagenase in the treatment of chronic 
wounds.
Conclusion: The study showed that nurses have knowledge that 
collagenase is a debriding enzyme that aids in the healing process, 
particularly by removing the necrotic tissue in wounds; however, there 
is still the need to improve the relevant knowledge concerning the use 
of this substance in dressings made in their chronic lesions, even in 
view of the apparent lack of knowledge about the relevant enzyme 
peculiarities, such as its mechanism of action.
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Introduction
Chronic wounds consist of injuries that have as characteristics a hig-
her demand of time for scar development. The lesions may last years 
to the development of an effective healing process, presenting great 
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potential for recurrence, as well as the presence of 
specific cells of the chronic inflammatory process at 
the local of the injury, for example, differentiated 
macrophages and lymphocytes, which differentia-
tes this type of wound from the others [1-2].
Chronic wounds such as neuropathic ulcers, pres-
sure ulcers and venous ulcers, are lesions that have a 
high morbidity and mortality, resulting in longer hos-
pital stays and negative impacts, both in the quality 
of life, as in health services due to high costs social 
and economic engaged in their treatment [3-4].
With the growing number of people who have 
lesions with these peculiarities, researchers and ad-
ministrators in the health sector have shown interest 
to be involved in this theme, in view of the impact 
of these injuries on the lives of individuals and, of 
course, the high hospital costs which they require 
[3-4].
For the treatment of wounds, there is a wide 
variety of products in the market, which ultimately 
require rigorous evaluation of tissue injury occurs so 
that the selection of the most appropriate coverage 
aiming to reach the appropriate treatment [5]. Thus, 
it is important that occurs thorough evaluation of 
the lesion from its source, location, size of the lesion 
bed characteristics, such as types of tissue present 
(vitalized or not), signs of infection and the presen-
ce of cavities, in addition adjacent skin. Systemic 
and psychosocial character condition of the patient 
should also be taken into account in the evaluation 
time, such as nutritional status, comorbidities, age, 
medications used, financial and social conditions to 
cooperate for the treatment and health keeping [6]. 
This fact will ensure the nurse accurate and actual 
situational conditions about the injury and it may 
take care holistically based on resolving interven-
tions.
In chronic wounds, in addition to the general 
characteristics evaluated, it is necessary to consider 
the peculiarities of this type of injury, since there is 
usually deficient endogenous collagenase produc-
tion, leading to failure in the removal of devitali-
zed tissues. This particularity makes one of topical 
products of choice for the treatment is preferably 
collagenase [6].
Collagenase is a topical debriding substance that 
acts by means of an enzyme called Clostridiopepti-
dase A., which promotes the removal of devitalized 
tissues. To be routinely used by health professio-
nals, especially nurses, it is necessary to have tech-
nical and scientific knowledge about this enzymatic 
debriding, because if used improperly it can make 
improper the formation of granulation tissue, and 
consequently delayed healing [3, 7-8].
For collagenase to be used properly and judi-
ciously, there is a priority for the nursing professio-
nal, as well as to know about this product used to 
treat wounds, systematize this assistance, thus per-
forming the steps of the nursing process through 
holistic and systematic evaluation the wound and 
the patient, thus enabling nurses to the construc-
tion and implementation of the treatment plan, 
monitoring, and documentation of results from 
the interventions, which will provide means for the 
attainment of its main objective included in the care 
process: the progression of injury, satisfying your 
customer [4, 6].
It is emphasized that currently the treatment of 
wounds is considered a multidisciplinary practice, 
which requires the joint efforts of health professio-
nals, but is nursing more accurately the clinical nurse 
who is in charge of decision making inherent in the 
process of care wounds, as well as the choice of the 
dressing and the substances used in the evolution 
of the injury process [9].
Such a fact requires from nurses autonomy and 
quality of service performed, thus requiring respon-
sibility and a broad knowledge from the professio-
nal. By the elucidated information, one can observe 
the importance of the role of nurses in all stages of 
the implementation process of care focused on the 
treatment of chronic skin lesions, but also the need 
for knowledge of all kinds of products used in the 
treatment these wounds, emphasizing collagenase, 
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as a cover for easy access to hospital services, one 
of the most used products in the clinical practice of 
nurses who treat chronic injuries.
Given the above, this study aimed to verify the 
skills of nurses regarding the use of collagenase in 
the treatment of chronic wounds.
Material and Method
This is a descriptive study of a qualitative approach, 
developed in the medical clinic of two hospitals in 
the city of João Pessoa – PB, during the months 
from September to December 2014. The selected 
hospitals named as Hospital A and Hospital B to 
anonymity of institutions were chosen for develo-
ping comprehensive care to people with chronic 
wounds, regardless of etiology, and for using the 
collagenase routinely, and quite often in the execu-
tion of dressing developed at both clinics, a fact that 
aroused interest in the study of the object.
The research population consisted of nurses wor-
king in the medical clinic of these hospitals. The 
sample behaved 14 nurses who met the following 
inclusion criteria: being a nurse, be in the Clinical 
Unit at the time of data collection, perform nursing 
care focused on the treatment of chronic wounds. 
They were used as exclusion criteria: nurses who 
were not present at the time of data collection 
and who did not perform the treatment of chronic 
wounds.
For data collection there was used a semi-struc-
tured script, applied as an interview with the active 
professional in the unit. The interview was recorded 
with the aid of an audio pickup device (MP3), and 
fully transcribed, opting for post-collection transcript 
so that the reliability of data could be preserved. 
Data collection was performed on the professional 
duty at a propitious time, not to interfere with the 
routine work of the study participant professional 
in preserved place.
Data analysis was given by the Content Analy-
sis method, which consists of a thematic categori-
zation of the content itself inserted in the speech 
of the interviewee through systematic techniques. 
Methodological further based on the method is gi-
ven by the analysis of the stages of content consis-
ting of: pre-analysis of the data collected, the ma-
terial exploitation and processing of the results [10].
For the research to be taken there were consi-
dered the provisions of the Resolution nº 466/12 
of the National Health Council which deals with 
research involving humans in force in the country, 
this resolution provides for the application of the 
signature of the Consent and Informed completed 
by participants, as well as Resolution nº 311/2007, 
COFEN, which provides for the code of ethics of 
nursing professionals. The project was approved 
by the Ethics Committee on Research, according to 
CAAE 17913813.9.0000.5188.
Results
There were interviewed 14 nurses working in the 
Medical Clinic, 10 respondents belonging to the 
Hospital A and 4 to Hospital B. From these, 12 
(86%) were female; 10 (71%) between 31-45 years 
old; 5 (35%) had more than ten years of profes-
sional experience; 8 (57%) professionals had bet-
ween 1-5 years of experience in the treatment of 
wounds; only 1 (7%) was specialized in Dermato-
logy Nursing, as shown in Table 1.
Table 1.  Distribution of nurses participating in the 
study according to the demographic and 
professional data. João Pessoa, PB, Brazil, 
2014.
Variables N %
Gender
Female 12 86
Male 2 14
Age (years)
18-25 1 8
26-30 -
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Regarding the perception of nurses in the use of 
collagenase during treatment of chronic wounds, 
after analysis of this content in the reports emerged 
the following categories:
1.  Knowledge about the collagenase action me-
chanism in the treatment of chronic wounds;
2.  Reasons for use and destruction collagenase in 
the treatment of chronic wounds.
1. Knowledge about the collagenase action mecha-
nism in the treatment of chronic wounds
The category reports the knowledge of nurses in 
relation to collagenase mechanism of action, indica-
ting that these professionals consider it a debriding 
operating principally in the removal of necrotic tis-
sue. While they claim erroneously that the collage-
nase is an autolytic debriding, it is clear that nurses 
have reasonable understanding regarding this en-
zymatic debriding.
I define as an anti-necrosis product. Because 
every time I use collagenase in the treatment, I 
see that there is a very easy detachment of the 
necrotic tissue present in the wound. It is a very 
good ointment.
Nurse 1.
[...] It is an excellent non-selective debriding and 
autolytic. Now, of course not, every stage of the 
wound I'll be able to use it. It will "do" for a 
period there is well stressed necrotic tissue, then 
I use.
Nurse 2.
So, collagenase is an excellent autolytic debride-
ment. It is present in our service and it is also used 
a lot here in the clinic. Of course, the only way 
we have is the form of ointment, and we, nurses, 
when we perform the bandages put it in the 
areas of necrosis, those darker, unviable tissue.
Nurse 4.
Collagenase is an autolytic debriding nonselecti-
ve well-known [...] widely used in various places, 
especially in those where we have not so many 
financial conditions to acquire. Here, for exam-
ple, it is widely used. I highly recommend the 
use to be a very good and also wonderful effect 
enzyme.
Nurse 5.
Besides considering collagenase as a strong debri-
ding agent, nurses also believe that it acts enabling 
the wound, allowing the injury to be evaluated af-
ter the removal of the devitalized tissue, as well as 
other forms of treatment that can be used.
It will just remove the macerated tissue, slough, 
necrotic, to provide a possible healing and pro-
gression of injury, mainly from the wound bed. 
It enables our assessment.
Nurse 6.
Variables N %
Age (years)
31-45 10 71
46-50 3 21
> 50 - -
Training time (years)
<1 - -
1-5 5 35
6-10 4 30
>10 5 35
Time of operation in the treatment of wounds (years)
<1 - -
1-5 8 57
6-10 6 43
>10 - -
Post-graduation
Specialization in Nursing 12 86
Specialization in Stomatherapy 
Dermatology
1 7
No specialization 1 7
Social Participation 1 7
Total 100 100
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[...] To help the debridement I use collagenase. It 
will act as a facilitator, because it acts faster [...] at 
certain stages of necrosis, but we have to know 
when to use it.
Nurse 7.  
It acts very well and gives me subsidies to assess 
the injury of more precise and clear, much faster 
than some other enzyme. I like to use it.
Nurse 3.
If it works by removing and enabling [...] so that 
then we can start with other therapeutic practices 
[...] it acts so mainly very well even in treatment.
Nurse 10.
2. Reasons for use and destruction collagenase in 
the treatment of chronic wounds
When asked about the withdrawal of collagenase 
in the treatment of chronic wounds, nurses gave 
favorable and unfavorable reasons in relation to the 
use of said debriding.
Concerning the reasons for use of nurses they 
emphasized the importance of collagenase treatment 
as well as the knowledge regarding the debriding 
order to use it properly.
[...] It is still useful for coagulation necrosis of 
when seeking accelerate this debridement. It is 
useful, it is not necessary to remove it, unless 
the institution chooses to papain, for example, 
another enzyme, but we have to have an enzy-
me, is important. The task is not to forbid the use 
of collagenase, is know how to use.
Nurse 9.
[...] If you know what time you will use a product, 
you will not extinguish it its practice of its use. If 
you know when you should use it, I would not 
withdraw it.
Nurse 8.
[...] I do use collagenase to know that it can in-
deed be used when necessary, as well as the 
great importance that has debriding. I would not 
give it, because I see that the wound evolves well 
when used properly and with adequate precau-
tions. The nurse has to know well the product to 
be able to enforce its use, and the collagenase is 
no different.
Nurse 10.
[...] When it refers to collagenase, I know it's a 
product that needs to be aware that the use is 
done correctly. In wounds that take a long time 
to heal, and that is necrosis, it is a great option. 
We use a lot here at the clinic, and the nurse 
knows there will be no problem, but rather a 
contribution to healing.
Nurse 11.
The reasons for destruction, nurses consider co-
llagenase association to a no longer recommended 
antibiotic, the risk of achieving viable tissues, and 
dependence on prescription so it can be used.
In addition to have the associated antibiotic, chlo-
ramphenicol, and this longer be an antibiotic that 
is well surpassed almost not used anymore, and 
it has a very rapid debriding action sometimes 
affects viable tissue if we let long time.
Nurse 6.
[...] Collagenase should not be used more today, 
because we almost no longer use, and doctors 
need to prescribe for us to use, after all is a form 
of treatment, so I believe that we should not use 
it in daily life.
Nurse 5.
I prefer rather not to use, you first need the doc-
tor who prescribe and it can achieve viable tis-
sues. I do not use on their own exactly for these 
reasons, even though nursing is responsible for 
this function. I do not use, in spite of it exist here.
Nurse 14.
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I think rather that it should be removed. You mi-
suse, and when you use has to be under medical 
prescription, so I believe it is no longer serving. 
Furthermore, a substitution by another enzyme 
also cover would be feasible, but a lot depends 
on several factors, such as access and cost [...].
Nurse 12.
There are also professionals who do not feel able 
to issue a decision-making position in this regard, 
justifying not know how to respond to questions 
and also ignore the cost/ benefit of other products.
I do not know, because there are many new subs-
tance, there are other products, cost/benefit, I 
believe I would have to do some research before 
answering, to be able to replace. I have no opi-
nion on this question no.
Nurse 13.
I cannot comment about it because I do not work 
with regulatory manufacturers. If I had more ac-
curate knowledge, I assure you that would posi-
tion me. So I guess I cannot.
Nurse 12.
I think when you do not know you cannot give an 
opinion, isn’t it? So, I am sincere in saying that I 
cannot contribute on this point, because I have no 
great safety to say something that might alienate 
the product of our practice, it is as viable for use.
Nurse 8.
I do not know how far I can argue about it, I'm 
not so sure to describe to you something, a deci-
sion-making within that scope. I say for sure that 
I cannot answer.
Nurse 14.
Discussion
The term comes from the French "débrider" which 
means "to give free rein to" and was introduced 
by Pierre Joseph Desault in the late 1700s, to treat 
wounds of war and noted that there were better 
healing when performed debridement. This tech-
nique has several benefits for healing because it 
allows better evaluation of the wound, reduces the 
potential for infection by reducing the load of mi-
croorganisms, removing biofilms and activating cell 
activity by removing physical barriers to the fully 
devitalized necrotic tissue. This fact is explained as 
the necrotic tissue leads to the release of endotox-
ins that inhibit keratinocyte activity, and fibroblast 
decreases the presence of senescent cells with less 
protein, and less ability to proliferate, negatively in-
fluencing the activity of tissue growth factor [11-12].
The debridement technique can be performed by 
means of three types: mechanical or surgical debri-
dement, consisting of a practical removal of necrotic 
tissue using instruments such as scalpel and curette; 
autolytic debridement comprising a selective remo-
val process of necrotic cells due to the action of 
digestive enzymes and endogenous being primarily 
developed from covers that leave the wet lesion 
bed, thus facilitating the arrival of cells in the scar 
region; enzymatic or chemical debridement, which 
is based on the use of degrading substances, such 
as enzymes which digest the necrotic tissue, thus 
facilitating the healing process and progression of 
wound [7, 13].
Collagenase is an enzyme agent used for the 
hydrolytic cleavage of collagen molecules, which 
are the main components those adhere non-viable 
tissue in the wound bed [15]. The specific proteo-
lytic activity of collagenase was isolated in 1950 by 
pioneers of Bioscience: Mandl, Seifter, Harper and 
their colleagues, and demonstrated the breakdown 
of collagen while maintaining the integrity of viable 
tissue in wounds [6]. What goes against the asser-
tion of some nurses, as they consider collagenase 
as a non-selective and autolytic debriding?
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Concerning the action of collagenase, most spee-
ches revealed that it acts mainly necrotic tissue, 
showing adequate knowledge of nurses, as the 
literature states that debriding provides cleaning in-
jury by removal of devitalized tissue (necrosis) and 
crusting formed [9].
One benefit of collagenase highlighted by nurses 
and supported by the literature, comprise the best 
conditions for evaluation of the wound after use 
of such debriding, since the enzymes topical digest 
and dissolve the devitalized tissue, enabling the 
wound and allowing viable tissues make it visible 
to the nurse, assisting in choosing treatments that 
promote the healing process [14].
Regarding the reasons for the use of collagena-
se, it is emphasized that nurses justified its use by 
having knowledge in relation to its mechanism of 
action as enzymatic debriding, and that its use be-
comes an important tool for the treatment of the 
wound. The care of people with wounds requires 
technical-scientific knowledge, with skill and inte-
gral vision to the patient, which is a need identified 
by own account of the participating nurses, when 
they express the importance of recognizing how to 
use the enzymatic debriding the care of the patient 
affected by this injury [15].
Concerning the non-use of collagenase, the spee-
ches of nurses refer to not use the ointment becau-
se of association with antibiotic chloramphenicol, 
and use restricted to prescription.
The association of collagenase with chloramphe-
nicol, it is emphasized that this is a bacteriostatic 
antibiotic of broad spectrum used to tackle local 
bacterial infections, low evidence of acquired re-
sistance. However, recognition of toxic effects that 
can cause serious damage to health as the gray 
baby syndrome and aplastic anemia, as well as the 
emergence of new, more effective and less toxic 
drugs, eventually restricting its use [17, 18]; while to-
pical use of antibiotics that do not expose the risks 
of destruction mentioned in the speeches justified 
by decreased collagenase production Chloramphe-
nicol with the pharmaceutical industry.
Nurses also reported dependence on prescription 
as a barrier to not use collagenase; however, the 
Regional Councils of São Paulo Nursing and the 
Federal District, after analysis of the legislation, say 
the technical trained nurse and scientifically has le-
gal support and autonomy to prescribe covers/rela-
ted and topical therapy as institutional protocols or 
health body [19, 20].
In addition to the lack of knowledge regarding 
the legislation governing the profession and gua-
ranteeing autonomy in the treatment of wounds, 
some nurses also showed uncertainty in positioning 
with respect to decisions regarding the use of that 
type of topical debriding treatment, not being able 
to issue opinion on its usefulness.
This may be a result of little or no workload for the 
treatment of wounds during the training of nurses, 
which reflects the lack of knowledge and/or even 
interest in wound care, since they were not motiva-
ted at the time of learning. This fact is reported in 
studies that show a lack of knowledge of nursing 
students regarding the treatment of wounds, which 
can result in care not based on scientific evidence, 
compromising the quality of nursing care for people 
with chronic wounds [5, 16].
Conclusion
The study showed that nurses have knowledge that 
collagenase is an enzyme debriding that aids in the 
healing process, especially removing the necrotic tis-
sue in chronic wounds. However, these professio-
nals have superficial knowledge regarding the use 
of this debriding with deficit especially in relation to 
its mechanism of action, which could end up en-
hancing the delay in the healing of chronic wounds. 
Thus, understanding that the nurse is primarily 
responsible for the treatment of wounds highlights 
the need to improve for the care of wounds syste-
matized and updated, ensuring the quality of care.
For this, it is essential that health services invest in 
continuing education activities, seeking to intervene 
in the needs identified from the health professionals 
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themselves, as well as the educational institutions 
extend the hours for the treatment of wounds, so 
that nurses possess adequate technical and scien-
tific skills to exercise care that is inherent in their 
profession. 
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